Health
Health News Update
STAT News reports on hantavirus and a new drug trial for genetic heart disease. The latter, Myqorzo, met twin efficacy goals in Phase 3.
Coverage timeline — 2 articles
STAT News
A Cytokinetics heart disease drug — already approved in one indication — succeeded in another Phase 3 trial, a potential boost for sales.
2026-05-05 11:30 UTC
STAT News
The latest on the abortion pill, paternal deaths, and more health news from Morning Rounds
2026-05-05 11:44 UTC